Non-inflammatory Degenerative Joint Disease (NIDJD)
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Zimmer BiometFL - Jacksonville
2 programsShoulder ArthroplastyN/A1 trial
Total Hip Arthroplasty with Longevity IT Oblique LinersN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Zimmer BiometTotal Hip Arthroplasty with Longevity IT Oblique Liners
Zimmer BiometShoulder Arthroplasty
Clinical Trials (2)
Total enrollment: 158 patients across 2 trials
MDR - Longevity IT Oblique and Offset Liners
Start: Aug 2023Est. completion: Nov 20246 patients
N/ATerminated
Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
Start: Oct 2012Est. completion: Mar 2026152 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.